We're very excited to be part of the highly innovative RNA ecosystem in NSW. Very much looking forward to seeing RNA Australia growing and making a difference in RNA research, innovation, and investment!
🚀 Exciting news for NSW's biotech sector! RNA Australia has officially launched, marking a significant step in developing a world-class RNA research and development ecosystem in the state. 🔬 RNA Australia, a joint venture between the NSW Government and NSW/ACT universities, will oversee the new RNA Research & Pilot Manufacturing Facility at Macquarie University. This facility will be among a handful globally, driving innovation in RNA therapeutics, vaccines, and delivery technologies. The newly appointed board will lead RNA Australia, bringing together diverse expertise from academia and industry: 🎆 Susan Petrellis GAICD Petrellis – Founder and Managing Director, Bounce Partners (Chair) 🎆 Emeritus Professor Alan Pettigrew – Fellow of Senate, University of Sydney 🎆 Petra Andrén – Former Head of Innovation Districts, Greater Cities Commission 🎆 Dr Phil Kearney – CEO of Axelia Oncology 🎆 Dr Elaine Stead – Principal, Main Sequence Ventures With a signed Operator Agreement between RNA Australia and Aurora Biosynthetics (a subsidiary of Myeloid Therapeutics), this venture is poised to elevate NSW’s biotech capabilities. For more information about the board members, visit our website https://lnkd.in/gZxKv_pP This initiative strengthens partnerships across universities, research organisations, and industry, supporting the translation of cutting-edge RNA research into impactful therapies for both humans and animals. #biotech #RNAresearch #NSWinnovation #healthcare #therapeutics #research
